Wikipedia:Articles for deletion/Nucleics


 * The following discussion is an archived debate of the proposed deletion of the article below. Please do not modify it. Subsequent comments should be made on the appropriate discussion page (such as the article's talk page or in a deletion review).  No further edits should be made to this page.  

The result of the debate was delete. Kirill Lokshin 05:08, 10 November 2005 (UTC)

Nucleics
Advertising - doesn't meet WP:CORP
 * Delete as per my nom. Dl yo ns 493   Ta lk  01:18, 4 November 2005 (UTC)

I had a look at the WP:CORP guidelines and it says that it is not against it if a company holds more than a 20% share of its market. Nucleics falls into this category.
 * Comment I'll be happy to be proved wrong on this and will withdraw nom on foot of verification of above.    Dl yo ns 493   Ta lk  12:58, 4 November 2005 (UTC)
 * Delete as per nom. *drew 04:25, 4 November 2005 (UTC)
 * Delete clear ad per nom jnothman talk 06:14, 4 November 2005 (UTC)
 * I wanted to vote Keep. However, I cannot find many third party sources to verify their importance as per WP:CORP. The only one that I could find was on the University of Technology, Sydney website see . No reports could be found in the Australian media for example If it could be proved that they had at least a 20% market share, I would vote Keep but I am abstaining for now. Capitalistroadster 08:35, 4 November 2005 (UTC)
 * Delete per nom -- NS LE  ( Commu nicate! ) < Contribs > 09:15, 4 November 2005 (UTC)
 * Note: This debate has been included in the list of Australia-related deletions.  Capitalistroadster 08:39, 4 November 2005 (UTC)
 * Delete per nom. --Holderca1 15:44, 4 November 2005 (UTC)
 * Delete, their primary activity is offering a DNA sequencing facility - I would guess that most universities in Australia have an equivalent facility.--nixie 02:26, 5 November 2005 (UTC)


 * Keep per nom and Peta -- Ian &equiv; talk 02:03, 7 November 2005 (UTC)


 * Keep Ill Dilettante 05:49, 7 November 2005 (UTC) The 20% figure is difficult to prove for private companies like Nucleics working in niche areas. Nucleics primary activity is not offering a DNA sequencing service, but software and reagents for improving DNA sequencing (as per the article). Nucleics has also been listed in Science as a supplier of DNA sequencing software Advances In : Genomics – Fresh Steps in Sequencing.


 * The above discussion is preserved as an archive of the debate. Please do not modify it. Subsequent comments should be made on the appropriate discussion page (such as the article's talk page or in a deletion review). No further edits should be made to this page.